Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
46.86
+0.02 (0.04%)
At close: Jun 20, 2025, 4:00 PM
46.99
+0.13 (0.28%)
After-hours: Jun 20, 2025, 7:59 PM EDT
BMY Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
34,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,396,950
Profits / Employee
$158,915
Market Cap
95.36B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
BMY News
- 1 day ago - I'm Buying Dividend Giants At Huge Discounts - Seeking Alpha
- 4 days ago - Bristol Myers Squibb Announces Dividend - Business Wire
- 5 days ago - Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi (lisocabtagene maraleucel) - Business Wire
- 9 days ago - Dividend Harvesting Portfolio Week 223: $22,300 Allocated, $2,310.77 In Projected Dividends - Seeking Alpha
- 9 days ago - Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025 - Business Wire
- 9 days ago - Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025 - Business Wire
- 10 days ago - Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 10 days ago - Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis - Business Wire